• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

To evaluate the efficacy of Tramadol administered epidurally along with 0.375 % Bupivacaine in patients undergoing lower limb surgeries

    Dr. Narayan Patil Dr. Anshul Agrawal Dr. Rahul Kumar Dr. Saroop Kour

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 1619-1623

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The aim of this study is to evaluate the efficacy of Tramadol administered epidurally along with 0.375 % Bupivacaine in patients undergoing lower limb surgeries. Patients with absolute contra- indication for epidural block like bleeding disorders or patients on anticoagulant therapy or MAO inhibitors, with raised intra–cranial tension, infection at the site of injection, with neurological deficit and with psychiatric diseases were not included in this study. Patients who were chronic abusers of benzodiazepines and painkillers were also excluded from this study.
Result: The time required for sensory blockade to reach maximum level and then regression to L1 level. There was no statistically significant diffrerence  between the two groups. Mean value for the onset of sensory blockade was found to be 11.55 ± 1.71 in group I and 11.35 ± 2.28 in group II. Max level of blockade achieved was usually between  T 7 to T 10 . The time required for motor blockade. There was no statistically significant diffrerence  between the two groups. None of them had any patient scoring bromage scale 2 . time of regression of motor blockade from bromage scale 1 to 0 were 141.10 ± 4.59 & 144.65 ± 2.22 in groups I & II respectively.
Conclusion: No sedative or analgesic was given as preoperative or intraoperatively. Group I. patients received  20ml of 0.375%  bupivacaine 0.5% plain + 100mg tramadol (2ml) at different intervals. Addition of tramadol to Bupivacaine epidurally proved to be efficacious for treatment of postoperative pain than analgesic effect of Bupivacaine alone.
Keywords:
    efficacy tramadol bupivacaine & limb surgeries
  • PDF (199 K)
  • XML
(2023). To evaluate the efficacy of Tramadol administered epidurally along with 0.375 % Bupivacaine in patients undergoing lower limb surgeries. European Journal of Molecular & Clinical Medicine, 9(3), 1619-1623.
Dr. Narayan Patil Dr. Anshul Agrawal Dr. Rahul Kumar Dr. Saroop Kour. "To evaluate the efficacy of Tramadol administered epidurally along with 0.375 % Bupivacaine in patients undergoing lower limb surgeries". European Journal of Molecular & Clinical Medicine, 9, 3, 2023, 1619-1623.
(2023). 'To evaluate the efficacy of Tramadol administered epidurally along with 0.375 % Bupivacaine in patients undergoing lower limb surgeries', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1619-1623.
To evaluate the efficacy of Tramadol administered epidurally along with 0.375 % Bupivacaine in patients undergoing lower limb surgeries. European Journal of Molecular & Clinical Medicine, 2023; 9(3): 1619-1623.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 4
  • PDF Download: 7
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus